Immuneel

Bengaluru, India · Founded 2018 · Privately Held (backing)

Developer of a cell therapy intended to provide cell and gene therapies for cancer treatment. Immuneel is based in Bengaluru, India and was founded in 2018. Its last known valuation is $67.9 million. It has raised $38 million.

Last price · $/share

—

Implied valuation

$67.9M

Total raised

$38.0M

Last round

—

How much has Immuneel raised?

$38.0Macross 0 recorded rounds

Free account

More of Immuneel with a free account

·The complete investor list: 16 names
·Watch Immuneel: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Immuneel investors

16 investors are on record for Immuneel, including Khosla Ventures, F-Prime Capital, Eight Roads and Ranjan Pai.

For fundraisers

Raising for a company like Immuneel?

16 investors have backed Immuneel.

See all 16 investors →

Frequently asked about Immuneel

How much has Immuneel raised?: Immuneel has raised $38.0M in total across 0 recorded funding rounds.